A Secondary Route of Viral Entry Could Explain Enhanced Pathogenicity of COVID-19
By Sahana Shankar, Ph.D. Candidate European researchers report that SARS-CoV-2’s entry into the host cells is facilitated by Neuropilin-1 (NRP1), a cell receptor that, when inhibited with a monoclonal antibody, …
Read More